Search Within

Samantha Nicole Reiss

Formats
  1. Journal Article (8)
  2. Meeting Abstract (6)
Groups
  1. Clinical Pharmacy Specialists (11)
  2. Biostatistics Service (5)
  3. Epidemiology and Biostatistics (5)
  4. Department of Medicine (3)
  5. Population Sciences Research Program (3)
  6. Hematologic Malignancies, Division of (2)

More Groups

People
  1. Lisa Modelevsky (10)
  2. Prakirthi Yerram (7)
  3. Christian Grommes (5)
  4. Larry Buie (4)
  5. Thomas Kaley (4)
  6. Anne Reiner (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (3)
  5. 2018 (1)
  6. 2017 (3)

More Years

Publications
  1. Neuro-Oncology (4)
  2. Blood (2)
  3. Annals of Hematology (1)
  4. Annals of Lymphoma (1)
  5. CNS Oncology (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. Oxford University Press (4)
  2. American Society of Hematology (2)
  3. Springer (2)
  4. AME Publishing Company (1)
  5. Biomed Central Ltd (1)
  6. Future Medicine (1)

More Publishers

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort
    Journal Article

    Yerram, P.; Reiss, S. N.; Modelevsky, L.; Schaff, L.; Reiner, A. S.; Panageas, K. S.; Grommes, C.
    Annals of Lymphoma (2023)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, carmustine, etoposide, and prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: A retrospective single-center study
    Journal Article

    Reiss, S. N.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City
    Journal Article

    Yerram, P.; Thackray, J.; Modelevsky, L. R.; Land, J. D.; Reiss, S. N.; Spatz, K. H.; Levoir, A. C.; Pak, T. K.; Dao, P. H.; Buege, M. J.; more...
    Journal of Oncology Pharmacy Practice (2021)

    Fulltext@MSK | Save
  • Increased number of high dose methotrexate cycles and the addition of rituximab is associated with better outcomes in a large primary CNSL cohort
    Meeting Abstract

    Yerram, P.; Reiss, S. N.; Modelevsky, L.; Schaff, L.; Reiner, A.; Panageas, K.; Grommes, C.
    Blood (2019)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, BCNU, etoposide, and prednisone (RMBVP) for the treatment of relapsed/recurrent primary central nervous system lymphoma: A retrospective single center study
    Meeting Abstract

    Reiss, S.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas
    Journal Article

    Yerram, P.; Reiss, S. N.; Modelevsky, L.; Gavrilovic, I. T.; Kaley, T.
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma
    Journal Article

    Modelevsky, L.; Tizon, R.; Reiss, S. N.; Smith, M.; Garonce, R.; Kaley, T.
    CNS Oncology (2018)

    Fulltext@MSK | Save
  • Prognostic factors and outcomes of patients with central nervous system (CNS) metastatic ALK-rearranged non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Kachur, E.; Reiss, S.; Land, J.; Buie, L.; Reiner, A.; Panageas, K.; Riely, G.; Pentsova, E.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Toxicity of single agent carmustine versus carmustine plus bevacizumab in patients with recurrent or progressive high grade gliomas
    Meeting Abstract

    Yerram, P.; Reiss, S.; Modelevsky, L.; Gavrilovic, I.; Kaley, T.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas
    Journal Article

    Reiss, S. N.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save